Novel strategies for adoptive therapy following HLA disparate transplants.


Transplants of SBA-E- allogeneic marrow or G-CSF mobilized CD34+ (ISOLEX) E- peripheral blood progenitor cells which are adequately depleted of T-cells, when administered without post-transplant immunosuppression now induce consistent engraftment with low incidences of acute and chronic GVHD both in HLA matched and HLA disparate recipients. Furthermore, the… (More)
DOI: 10.1016/j.beha.2011.06.001


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics